Unaudited Forward-Looking Statements Regarding Business Outlook
| ||||||
Business Outlook |
| Three Months Ending December 31, 2022 | ||||
|
|
| GAAP Measure |
| Non-GAAP Adjustments* |
| Non-GAAP Measure |
Gross margin |
| 60 % |
| 0 % |
| 60 % |
|
|
|
|
|
|
|
|
Operating expenses |
| $132 |
| $(23) |
| $109 |
|
|
|
|
|
|
|
|
Effective tax rate |
| 35 % |
| (10) % |
| 25 % |
|
|
|
|
|
|
|
|
Diluted earnings per share - low |
| $0.35 |
| $0.58 |
| $0.93 |
|
|
|
|
|
|
|
|
Diluted earnings per share - high |
| $0.45 |
| $0.58 |
| $1.03 |
|
| ||||||
* Non-GAAP adjustments include the following estimates: stock compensation expense of $16.9 million, intangible asset
|
Silicon Laboratories Inc.
| |||
|
| October 1, 2022 |
| January 1,
|
Assets |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents | $ 483,277 |
| $1,074,623 |
Short-term investments | 893,131 |
| 964,582 |
Accounts receivable, net | 76,672 |
| 98,313 |
Inventories | 88,447 |
| 49,307 |
Prepaid expenses and other current assets | 84,109 |
| 51,748 |
Total current assets | 1,625,636 |
| 2,238,573 |
Property and equipment, net | 151,610 |
| 146,516 |
| Goodwill | 376,389 |
| 376,389 |
| Other intangible assets, net | 91,650 |
| 118,978 |
| Other assets, net | 91,012 |
| 77,839 |
| Total assets | $2,336,297 |
| $2,958,295 |
|
| |||
|
|
|
|
|
| Liabilities and Stockholders' Equity |
|
|
|
| Current liabilities: |
|
|
|
| Accounts payable | $ 81,676 |
| $ 47,327 |
| Current portion of convertible debt, net | -- |
| 450,599 |
| Deferred revenue and returns liability | 11,705 |
| 13,849 |
| Other current liabilities | 112,320 |
| 157,052 |
| Total current liabilities | 205,701 |
| 668,827 |
| Convertible debt, net | 529,062 |
| -- |
| Other non-current liabilities | 49,890 |
| 77,044 |
| Total liabilities | 784,653 |
| 745,871 |
| Commitments and contingencies |
|
|
|
| Stockholders' equity: |
|
|
|
| Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued | -- |
| -- |
| Common stock – $0.0001 par value; 250,000 shares authorized; 33,530 and 38,481 shares issued and outstanding at October 1, 2022 and January 1, 2022, respectively | 3 |
| 4 |
| Retained earnings | 1,568,108 |
| 2,214,839 |
| Accumulated other comprehensive loss | (16,467) |
| (2,419) |
| Total stockholders' equity | 1,551,644 |
| 2,212,424 |
| Total liabilities and stockholders' equity | $2,336,297 |
| $2,958,295 |
